COLAZAL vs M.V.C. 9+3

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. COLAZAL and M.V.C. 9+3 are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	COLAZAL	M.V.C. 9+3
Rating	74/100	New
Pharmacy pays	~$11.02 /30	—
Type	RX	RX
Active ingredient	BALSALAZIDE DISODIUM	ASCORBIC ACID AND BIOTIN AND CYANOCOBALAMIN AND DEXPANTHENOL AND ERGOCALCIFEROL AND FOLIC ACID AND NIACINAMIDE AND PYRIDOXINE HYDROCHLORIDE AND RIBOFLAVIN 5'-PHOSPHATE SODIUM AND THIAMINE HYDROCHLORIDE AND VITAMIN A AND VITAMIN E
Manufacturer	Valeant Pharm Intl	Abraxis Pharm
Dosage forms	Capsule	Injectable
Drug class	Aminosalicylate	—
Boxed warning	None	None
Treats	Ulcerative Colitis	—

colazal m.v.c. 9+3

Rating

74/100

New

Pharmacy pays

~$11.02 /30

—

Type

Active ingredient

BALSALAZIDE DISODIUM

ASCORBIC ACID AND BIOTIN AND CYANOCOBALAMIN AND DEXPANTHENOL AND ERGOCALCIFEROL AND FOLIC ACID AND NIACINAMIDE AND PYRIDOXINE HYDROCHLORIDE AND RIBOFLAVIN 5'-PHOSPHATE SODIUM AND THIAMINE HYDROCHLORIDE AND VITAMIN A AND VITAMIN E

Manufacturer

Valeant Pharm Intl

Abraxis Pharm

Dosage forms

Capsule

Injectable

Drug class

Aminosalicylate

—

Boxed warning

None

Treats

Ulcerative Colitis

—

Frequently asked questions

What is the difference between Colazal and M.V.C. 9+3?

Colazal contains Balsalazide Disodium, while M.V.C. 9+3 contains Ascorbic Acid and Biotin and Cyanocobalamin and Dexpanthenol and Ergocalciferol and Folic Acid and Niacinamide and Pyridoxine Hydrochloride and Riboflavin 5'-Phosphate Sodium and Thiamine Hydrochloride and Vitamin A and Vitamin E — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.